Translational Research Institute
Academic Health System, Hamad Medical Corporation
The main focus of Dr. Shahab’s research is to identify and characterize the dysregulated signaling pathways involved in the development of human diseases, especially in cancer. Dr. Shahab leads Molecular pathophysiology core that supports HMC physicians for transnational research. He has published more than 230 peer-reviewed research papers with citation 11283, h-index 64 and i10-index 172. Recently he has been listed in World's Top 2% Scientists by Stanford University.